Have a personal or library account? Click to login
Acta Pharmaceutica Cover

Acta Pharmaceutica

The Journal of Croatian Pharmaceutical Society

Open Access
1,4
Impact Factor
4,5
CiteScore
Journal detailsArticles & issues

About the journal

Acta Pharmaceutica is an international, scientific, multidisciplinary journal, devoted to the pharmaceutical and allied sciences, which contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. ...

View full aims & scope

Editor-in-chief

Svjetlana Luterotti
Zagreb, Croatia
View full editorial board

All volumes and issues in this journal

Open Access
|Oct 2025
Development of two different eco-friendly label-free platforms for analysis of selumetinib
Open Access
|Oct 2025
Phytochemical composition, antioxidant, antiglycation, and antihyperlipidemic activity of flowering parts from five plant species before and after in vitro digestion
Open Access
|Oct 2025
Combined shake-flask, chromatographic and in silico approaches for evaluating the physicochemical and ADME properties of aloin A and aloe-emodin
Open Access
|Oct 2025
Scutellarin mitigates LPS-ATP-induced cardiomyocyte pyroptosis through the inhibition of the NLRP3/caspase-1/GSDMD signalling pathway
Open Access
|Oct 2025
Synthesis of magnetic N-doped carbon dots as pH-responsive targeted molecule cargo and its antioxidant and antibacterial behaviour
Open Access
|Oct 2025
From in vitro studies to product information useful for patients: Evaluation of physical properties and the stability of nasal spray devices containing hydroxypropyl methylcellulose-based liquid and powder formulations

Journal details

Aims and scope

Acta Pharmaceutica (AP) is an international, scientific, multidisciplinary journal, devoted to the pharmaceutical and allied sciences, which contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With a strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice, in the form of preliminary and short communications, original research papers and reviews. Book reviews are published also.

AP is a quarterly, single-blind peer-reviewed journal in biomedicine with fully open access and “early bird” platform. All articles are submitted to scrutinized evaluation and fair judgement. AP above all puts scientific honesty and integrity.

To reach the highest standards in publication ethics all the parties (authors, editors, reviewers) are required to behave responsibly and ethically. This implies submittance by authors on an exclusive basis, of only their own and new data; novelty and originality are prioritized. Also, secure handling of confidential data by reviewers and editors is a must.

AP is indexed in numerous world top international bibliographic bases, like Clarivate Analytics´s Web of Science® Core Collection (SCI-Expanded, JCR/Science Edition, etc.), EMBASE/Excerpta Medica, MEDLINE/PubMed, Scopus/SCImago, and others. According to SCImago JR it is a Q2 journal (pharmaceutical sciences) with a steadily increasing Clarivate JIF value reaching 2.8 in 2022.

Topics covered are:

  • drug design
  • molecular modelling/docking studies
  • pharmaceutical chemistry/medicinal chemistry
  • drug metabolism
  • analytics of drugs
  • pharmaceutical technology/formulation studies/nanosystems/cosmetology
  • pharmaceutical biotechnology
  • pharmaceutics/biopharmacy (including pharmacokinetics) and pharmacodynamics
  • drug delivery/disposition and stability
  • pharmacognosy and phytopharmacy
  • pharmacology (clinical and animal)
  • toxicology
  • clinical pharmacy
  • pharmacovigilance
  • pharmaceutical and clinical biochemistry
  • pharmaceutical biology with genetics/pharmacogenomics/cell biology
  • pharmacoepidemiology/pharmacoeconomics/social pharmacy
  • physical pharmacy
  • radiopharmaceuticals
  • medicine (including diagnostics and therapy)
  • peptide and protein chemistry/protein design

Why subscribe and read

  • To get informed on the latest research in pharmaceutical and related sciences.

Why submit

  • fair and constructive peer review by the experts in the field,
  • editorial help and language revision services,
  • articles abstracted by online indexing services,
  • listed in WoS MJL by Clarivate.
eISSN: 1846-9558|ISSN: 1330-0075|Language: English|Publication frequency: 4 times per year
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects: Pharmacy, Pharmacy, other